Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
Public ClinicalTrials.gov record NCT00581360. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Head and Neck Adenoid Cystic Carcinoma
Study identification
- NCT ID
- NCT00581360
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of Pittsburgh
- Other
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Interventions
- doxorubicin and bortezomib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2007
- Primary completion
- May 31, 2011
- Completion
- May 31, 2011
- Last update posted
- Nov 6, 2016
2007 – 2011
United States locations
- U.S. sites
- 21
- U.S. states
- 2
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UPMC Cancer Center - Teramana Cancer Center - Steubenville | Steubenville | Ohio | 43952 | — |
| UPMC Cancer Center - Beaver | Beaver | Pennsylvania | 15009 | — |
| UPMC Cancer Center - Clairton | Clairton | Pennsylvania | 15025 | — |
| UPMC Cancer Center - Arnold Palmer Pavilion - Greensburg | Greensburg | Pennsylvania | 15601 | — |
| UPMC Cancer Center - Oakbrook Commons - Greensburg | Greensburg | Pennsylvania | 15601 | — |
| UPMC Cancer Center - Indiana | Indiana | Pennsylvania | 15701 | — |
| UPMC Cancer Center - John P. Murtha Pavilion - Johnstown | Johnstown | Pennsylvania | 15901 | — |
| UPMC Cancer Center - McKeesport | McKeesport | Pennsylvania | 15132 | — |
| UPMC Cancer Center -Haymaker Rd. | Monroeville | Pennsylvania | 15146 | — |
| UPMC Cancer Center -Mosside Blvd. | Monroeville | Pennsylvania | 15146 | — |
| UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group | Moon Township | Pennsylvania | 15108 | — |
| UPMC Cancer Center -Mt. Pleasant | Mount Pleasant | Pennsylvania | 15666 | — |
| UPMC Cancer Center -New Castle | New Castle | Pennsylvania | 16105 | — |
| UPMC Cancer Center -Delafield Rd. | Pittsburgh | Pennsylvania | 15215 | — |
| UPMC Cancer Center - Mercy | Pittsburgh | Pennsylvania | 15219 | — |
| University of Pittsburgh Cancer Institute-Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| UPMC Cancer Center - Passavant | Pittsburgh | Pennsylvania | 15237 | — |
| UPMC Cancer Center -Drake | Pittsburgh | Pennsylvania | 15241 | — |
| UPMC Cancer Center - Uniontown | Uniontown | Pennsylvania | 15401 | — |
| UPMC Cancer Center - Washington | Washington | Pennsylvania | 15301 | — |
| UPMC Cancer Center -Wexford | Wexford | Pennsylvania | 15090 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00581360, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2016 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00581360 live on ClinicalTrials.gov.